Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes.

Human papillomavirus (HPV) infection, particularly type 16, is causally associated with cancer of the uterine cervix. The persistence or progression of cervical lesions suggests that viral antigens are not adequately presented to the immune system. This hypothesis is reinforced by the observation that most squamous intra-epithelial lesions show quantitative and functional alterations of Langerhans cells (LCs). Moreover, E-cadherin-dependent adhesion of LC to keratinocytes (KCs) is defective in cervical HPV16-associated (pre)neoplastic lesions. The possible role of viral oncoprotein E7 in the reduced levels of cell surface E-cadherin was investigated by silencing HPV16 E7 by RNA interference (siRNA). This treatment induced an increased cell surface E-cadherin expression in HPV16-positive KC and a significant adhesion of LC to these squamous cells. The E-cadherin re-expression following HPV16 E7 silencing was associated with increased detection levels of retinoblastoma protein and the activating protein (AP)-2alpha transcription factor. These data suggest that HPV16 E7-induced alterations of LC/KC adhesion may play a role in the defective immune response during cervical carcinogenesis.

[1]  P. Delvenne,et al.  Defensins induce the recruitment of dendritic cells in cervical human papillomavirus‐associated (pre)neoplastic lesions formed in vitro and transplanted in vivo , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  P. Delvenne,et al.  MIP3 alpha stimulates the migration of Langerhans cells in models of human papillomavirus (HPV)-associated (pre)neoplastic epithelium , 2007, Cancer Immunology, Immunotherapy.

[3]  J. McCoy,et al.  The E7 Oncoprotein Is Translated from Spliced E6*I Transcripts in High-Risk Human Papillomavirus Type 16- or Type 18-Positive Cervical Cancer Cell Lines via Translation Reinitiation , 2006, Journal of Virology.

[4]  J. McCoy,et al.  Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells , 2006, Oncogene.

[5]  P. Delvenne,et al.  E‐cadherin‐dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus‐associated (pre)neoplastic lesions , 2005, The Journal of pathology.

[6]  P. Delvenne,et al.  Production of large numbers of Langerhans' cells with intraepithelial migration ability in vitro , 2005, Experimental dermatology.

[7]  B. Williams,et al.  RNA interference and double-stranded-RNA-activated pathways. , 2004, Biochemical Society transactions.

[8]  P. Delvenne,et al.  Epithelial metaplasia: an inadequate environment for antitumour immunity? , 2004, Trends in immunology.

[9]  R. Iggo,et al.  Determinants of interferon-stimulated gene induction by RNAi vectors. , 2004, Differentiation; research in biological diversity.

[10]  K. Pienta,et al.  The role of an 80 kDa fragment of E-cadherin in the metastatic progression of prostate cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  Robert H. Silverman,et al.  Activation of the interferon system by short-interfering RNAs , 2003, Nature Cell Biology.

[12]  J. Doorbar,et al.  Depletion of Langerhans Cells in Human Papillomavirus Type 16-Infected Skin Is Associated with E6-Mediated Down Regulation of E-Cadherin , 2003, Journal of Virology.

[13]  E. Fearon.  Connecting estrogen receptor function, transcriptional repression, and E-cadherin expression in breast cancer. , 2003, Cancer cell.

[14]  M. Fraga,et al.  The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors , 2003, Journal of Cell Science.

[15]  J. Milner,et al.  Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference , 2002, Oncogene.

[16]  F. Hirsch,et al.  The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. , 2002, Lung cancer.

[17]  E. Fearon,et al.  The SLUG zinc-finger protein represses E-cadherin in breast cancer. , 2002, Cancer research.

[18]  P. Delvenne,et al.  Influence of the mucosal epithelium microenvironment on Langerhans cells: Implications for the development of squamous intraepithelial lesions of the cervix , 2002, International journal of cancer.

[19]  H. Hausen,et al.  Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis , 2002, Oncogene.

[20]  K. Münger,et al.  Degradation of the Retinoblastoma Tumor Suppressor by the Human Papillomavirus Type 16 E7 Oncoprotein Is Important for Functional Inactivation and Is Separable from Proteasomal Degradation of E7 , 2001, Journal of Virology.

[21]  S. Caldeira,et al.  Induction of pRb Degradation by the Human Papillomavirus Type 16 E7 Protein Is Essential To Efficiently Overcome p16INK4a-Imposed G1 Cell Cycle Arrest , 2001, Journal of Virology.

[22]  B. Boyer,et al.  Induction and regulation of epithelial-mesenchymal transitions. , 2000, Biochemical pharmacology.

[23]  Harald zur Hausen,et al.  Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis , 2000 .

[24]  Francisco Portillo,et al.  The transcription factor Snail controls epithelial–mesenchymal transitions by repressing E-cadherin expression , 2000, Nature Cell Biology.

[25]  A. G. Herreros,et al.  The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells , 2000, Nature Cell Biology.

[26]  P. Delvenne,et al.  Colonization of in vitro-formed cervical human papillomavirus- associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colony-stimulating factor. , 1999, The American journal of pathology.

[27]  S. Riethdorf,et al.  Expression of the MCP-1 Gene and the HPV 16 E6/E7 Oncogenes in Squamous Cell Carcinomas of the Cervix uteri and Metastases , 1998, Pathobiology.

[28]  P. Delvenne,et al.  In vitro propagated dendritic cells from patients with human-papilloma virus-associated preneoplastic lesions of the uterine cervix: use of Flt3 ligand , 1998, Cancer Immunology, Immunotherapy.

[29]  C. Muchardt,et al.  RB and c-Myc Activate Expression of the E-Cadherin Gene in Epithelial Cells through Interaction with Transcription Factor AP-2 , 1998, Molecular and Cellular Biology.

[30]  K. Münger,et al.  Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein , 1997, Journal of virology.

[31]  M. Mareel,et al.  Inactivation of retinoblastoma family proteins by SV40 T antigen results in creation of a hepatocyte growth factor/scatter factor autocrine loop associated with an epithelial-fibroblastoid conversion and invasiveness. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[32]  D. Wazer,et al.  E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. , 1996, Cancer research.

[33]  J. Hay,et al.  A method for tracking the migration of blood lymphocytes. , 1996, Immunological investigations.

[34]  V. Moreno,et al.  Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .

[35]  P. Fisher,et al.  Cell cycle arrest. , 1995, Science.

[36]  K. Hodivala,et al.  Evidence that cadherins play a role in the downregulation of integrin expression that occurs during keratinocyte terminal differentiation , 1994, The Journal of cell biology.

[37]  C. Woodworth,et al.  Comparative lymphokine secretion by cultured normal human cervical keratinocytes, papillomavirus-immortalized, and carcinoma cell lines. , 1993, The American journal of pathology.

[38]  M. Amagai,et al.  Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin , 1993, Nature.

[39]  J. Nevins,et al.  Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  J. Nevins,et al.  Analysis of trans activation by human papillomavirus type 16 E7 and adenovirus 12S E1A suggests a common mechanism , 1991, Journal of virology.

[41]  T. Sugimura,et al.  Purification and characterization of human papillomavirus type 16 E7 protein with preferential binding capacity to the underphosphorylated form of retinoblastoma gene product , 1991, Journal of Virology.

[42]  C. Bucana,et al.  Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. , 1990, Journal of immunology.

[43]  C. Meyers,et al.  The E7 proteins of the nononcogenic human papillomavirus type 6b (HPV-6b) and of the oncogenic HPV-16 differ in retinoblastoma protein binding and other properties , 1990, Journal of virology.

[44]  P. Delvenne,et al.  Inverse modulation of intraepithelial Langerhans' cells and stromal macrophage/dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix , 2004, Virchows Archiv.

[45]  K. Wada,et al.  Role of bombesin (BN)-like peptides/receptors in emotional behavior by comparison of three strains of BN-like peptide receptor knockout mice , 2002, Molecular Psychiatry.

[46]  P. Delvenne,et al.  Detection of human papillomaviruses in paraffin-embedded biopsies of cervical intraepithelial lesions: analysis by immunohistochemistry, in situ hybridization, and the polymerase chain reaction. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.